Key Findings
Ilika, a UK-based developer of solid-state battery technology, has successfully completed a funding round, securing £4.56 million (approximately $5.7 million USD). This significant capital injection is earmarked for capital expenditures to accelerate the commercialization of its two key product lines, Stereax and Goliath. The investment aims to further enhance Ilika’s competitive standing across a wide range of high-value applications in medical implants, electric vehicles (EVs), and defense sectors.
Technical Details
Ilika specializes in developing solid-state batteries based on its proprietary thin-film technology, offering two distinct product lines: Stereax for miniaturized medical devices and Goliath for larger-scale EV and industrial applications. Stereax batteries are suitable for medical implants and wearable devices requiring low power consumption and long lifespans, where safety and reliability are paramount. Goliath, on the other hand, is designed to meet the high energy density and fast-charging demands of EV and defense applications. The company has already commenced shipping 10Ah solid-state battery prototype samples to automotive and industrial customers, providing tangible evidence of its technology’s steady transition from laboratory-level to practical implementation. These prototypes will undergo customer evaluation, aiming for eventual adoption in future mass-produced models.
Background & Context
Solid-state batteries are at the forefront of global R&D competition as a next-generation power source poised to address the safety, energy density, and cycle life limitations of existing lithium-ion batteries. The UK government is strategically supporting domestic battery technology development, and the investment in Ilika is part of this broader initiative. In the medical field, compact and highly safe power sources are critical, while the defense sector demands reliability and performance under extreme conditions. The EV market faces urgent challenges in extending range and reducing charging times, which Ilika’s technology aims to resolve.
Strategic Significance & Outlook
This funding and capital investment will strengthen Ilika’s foundation for expanding its commercial production capacity and securing market share in high-growth sectors. The adoption of its technology across diverse fields such as medical, EV, and defense will diversify the company’s revenue streams and enhance its stability. Notably, the shipment of prototype samples to customers not only demonstrates the technology’s credibility but also heightens expectations for early commercial agreements. Moving forward, Ilika is expected to focus on establishing mass production techniques and improving cost efficiency, aiming for leadership in the global solid-state battery market.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments